BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17017971)

  • 1. Pharmacophore models for metabotropic 5-HT receptor ligands.
    Bojarski AJ
    Curr Top Med Chem; 2006; 6(18):2005-26. PubMed ID: 17017971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of serotonin 5-HT
    Thirumaran SL; Lepailleur A; Rochais C
    Eur J Med Chem; 2019 Dec; 183():111705. PubMed ID: 31581003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
    López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
    Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latest advances towards the discovery of 5-HT(7) receptor ligands.
    Pittala V; Pittala D
    Mini Rev Med Chem; 2011 Nov; 11(13):1108-21. PubMed ID: 22353220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.
    Molderings GJ; Frölich D; Likungu J; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):272-80. PubMed ID: 8692281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic overview of new molecules with 5-HT1A binding affinities.
    Pessoa-Mahana H; Araya-Maturana R; Saitz CB; Pessoa-Mahana DC
    Mini Rev Med Chem; 2003 Mar; 3(2):77-93. PubMed ID: 12570842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT
    Romeo G; Salerno L; Pittalà V; Candido M; Intagliata S; Amata E; Salmona M; Cagnotto A; Rescifina A; Floresta G; Modica MN
    Eur J Med Chem; 2019 Dec; 183():111690. PubMed ID: 31526973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GR-127935-sensitive mechanism mediating hypotension in anesthetized rats: are 5-HT5B receptors involved?
    Sánchez-Maldonado C; López-Sánchez P; Anguiano-Robledo L; Leopoldo M; Lacivita E; Terrón JA
    J Cardiovasc Pharmacol; 2015 Apr; 65(4):335-41. PubMed ID: 25502305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminotriazines with indole motif as novel, 5-HT
    Kułaga D; Jaśkowska J; Satała G; Latacz G; Śliwa P
    Bioorg Chem; 2020 Nov; 104():104254. PubMed ID: 32919133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the discovery of selective and non-selective 5-HT(1D) receptor ligands.
    Ward SE; Watson JM
    Curr Top Med Chem; 2010; 10(5):479-92. PubMed ID: 20166947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetrahydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine7 receptor.
    Kikuchi C; Ando T; Watanabe T; Nagaso H; Okuno M; Hiranuma T; Koyama M
    J Med Chem; 2002 May; 45(11):2197-206. PubMed ID: 12014957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular design based on 3D-pharmacophore. Application to 5-HT4 receptor.
    Bureau R; Daveu C; Lemaître S; Dauphin F; Landelle H; Lancelot JC; Rault S
    J Chem Inf Comput Sci; 2002; 42(4):962-7. PubMed ID: 12132898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
    Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
    Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins.
    Kim HJ; Yun HM; Kim T; Nam G; Roh EJ; Kostenis E; Choo HY; Pae AN; Rhim H
    Comb Chem High Throughput Screen; 2008 May; 11(4):316-24. PubMed ID: 18473741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology.
    Marazziti D; Baroni S; Borsini F; Picchetti M; Vatteroni E; Falaschi V; Catena-Dell'Osso M
    Curr Med Chem; 2013; 20(3):371-7. PubMed ID: 23157629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis.
    Wang YQ; Lin WW; Wu N; Wang SY; Chen MZ; Lin ZH; Xie XQ; Feng ZW
    Acta Pharmacol Sin; 2019 Sep; 40(9):1138-1156. PubMed ID: 30814658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
    Bielenica A; Kozioł AE; Struga M
    Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,2,5-Thiadiazole derivatives are potent and selective ligands at human 5-HT1A receptors.
    Sabb AL; Vogel RL; Kelly MG; Palmer Y; Smith DL; Andree TH; Schechter LE
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1069-71. PubMed ID: 11327592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NEW SPIROHYDANTOIN DERIVATIVES - SYNTHESIS, PHARMACOLOGICAL EVALUATION, AND MOLECULAR MODELING STUDY.
    Czopek A; Zagorska A; Kolaczkowski M; Bucki A; Gryzlo B; Rychtyk J; Pawlowsk M; Siwek A; Satala G; Bojarski A; Kubacka M; Filipek B
    Acta Pol Pharm; 2016 Nov; 73(6):1545-1554. PubMed ID: 29634109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.